Fuller & Thaler Asset Management Inc. Buys 124,216 Shares of Doximity, Inc. (NASDAQ:DOCS)

Fuller & Thaler Asset Management Inc. lifted its position in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) by 8.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,579,708 shares of the company's stock after purchasing an additional 124,216 shares during the quarter. Fuller & Thaler Asset Management Inc. owned approximately 0.85% of Doximity worth $84,341,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. FMR LLC boosted its position in shares of Doximity by 37.6% during the 4th quarter. FMR LLC now owns 9,409,313 shares of the company's stock valued at $502,363,000 after acquiring an additional 2,571,580 shares in the last quarter. Arrowstreet Capital Limited Partnership boosted its holdings in Doximity by 708.7% during the fourth quarter. Arrowstreet Capital Limited Partnership now owns 1,510,416 shares of the company's stock valued at $80,641,000 after purchasing an additional 1,323,634 shares in the last quarter. Invesco Ltd. grew its stake in shares of Doximity by 525.1% in the 4th quarter. Invesco Ltd. now owns 1,272,403 shares of the company's stock valued at $67,934,000 after purchasing an additional 1,068,849 shares during the period. Franklin Resources Inc. raised its holdings in shares of Doximity by 1,178.3% in the 4th quarter. Franklin Resources Inc. now owns 1,062,211 shares of the company's stock worth $56,711,000 after buying an additional 979,113 shares in the last quarter. Finally, Lord Abbett & CO. LLC bought a new position in shares of Doximity during the 3rd quarter worth approximately $29,453,000. Institutional investors own 87.19% of the company's stock.

Insiders Place Their Bets

In related news, Director Timothy S. Cabral sold 20,000 shares of the business's stock in a transaction on Monday, February 3rd. The shares were sold at an average price of $57.62, for a total value of $1,152,400.00. Following the transaction, the director now owns 6,360 shares in the company, valued at $366,463.20. The trade was a 75.87 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 37.40% of the company's stock.

Doximity Price Performance

Shares of Doximity stock traded up $0.38 during midday trading on Friday, reaching $56.67. The company had a trading volume of 1,364,010 shares, compared to its average volume of 1,992,882. The stock has a fifty day moving average price of $60.70 and a 200 day moving average price of $56.19. Doximity, Inc. has a fifty-two week low of $22.96 and a fifty-two week high of $85.21. The firm has a market cap of $10.58 billion, a PE ratio of 56.67, a P/E/G ratio of 4.10 and a beta of 1.41.

Wall Street Analysts Forecast Growth

DOCS has been the topic of a number of analyst reports. Bank of America upped their price target on Doximity from $54.00 to $57.00 and gave the company a "neutral" rating in a research report on Monday, January 6th. Raymond James reiterated an "outperform" rating and set a $83.00 target price (up previously from $65.00) on shares of Doximity in a research report on Friday, February 7th. Needham & Company LLC boosted their price target on shares of Doximity from $65.00 to $82.00 and gave the company a "buy" rating in a research report on Friday, February 7th. Mizuho upped their price objective on shares of Doximity from $55.00 to $65.00 and gave the stock a "neutral" rating in a research note on Monday, February 10th. Finally, Leerink Partners upgraded shares of Doximity from a "market perform" rating to an "outperform" rating and lifted their target price for the company from $60.00 to $90.00 in a research note on Friday, February 7th. Eleven investment analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $65.39.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.